Disease | Author (year) | Pooled SIR or RR for all cancers | Tumor types with increased risk |
Rheumatoid arthritis | Simon (2015)[1] | 1.09 (1.06, 1.13) | Lymphoma (Hodgkin, non-Hodgkin), lung, melanoma |
Systemic lupus erythematosus | Bernatsky (2013)[2] | 1.14 (1.05, 1.23) | Lymphoma (non-Hodgkin), lung, leukemia, thyroid |
Systemic sclerosis (scleroderma) | Onishi (2013)[3] | 1.41 (1.18, 1.68) | Lung, liver, hematologic, bladder |
Myositis | |||
| Yang (2015)[4] | 1.62 (1.19, 2.04) | Lung, kidney, breast, lymphoma, bladder, endometrial, cervical, thyroid, brain |
| 5.50 (4.31, 6.70) | Ovary, breast, lung, colorectal, cervical, bladder, nasopharyngeal, esophagus, pancreas, kidney | |
Sjögren's disease | Liang (2014)[5] | 1.53 (1.17, 1.88) | Non-Hodgkin lymphoma, thyroid |
ANCA-associated vasculitis | Shang (2015)[6] | 1.74 (1.37, 2.21) | Non-melanoma skin, leukemia, bladder, lymphoma, liver, lung |
Reproduced from: Egiziano G, Bernatsky S, Shah AA. Cancer and autoimmunity: Harnessing longitudinal cohorts to probe the link. Best Pract Res Clin Rheumatol 2016; 30:53. Table used with the permission of Elsevier Inc. All rights reserved.